A Novel Connexin 30 Mutation in Clouston Syndrome  by Smith, Frances J.D. et al.
MUTATION REPORT
A Novel Connexin 30 Mutation in Clouston Syndrome
Frances J. D. Smith, Susan M. Morley,* and W. H. Irwin McLean
Epithelial Genetics Group, Human Genetics Unit, Department of Molecular and Cellular Pathology, and *Department of Dermatology, Ninewells
Medical School, Dundee, U.K.
Clouston syndrome (hidrotic ectodermal dysplasia) is
an autosomal dominant ectodermal dysplasia charac-
terized by alopecia, palmoplantar hyperkeratosis,
and nail dystrophy. Recently, mutations in the GJB6
gene encoding the gap junction protein connexin 30
have been shown to cause this disorder. To date, all
mutations have involved two codons: G11R and
A88V. Here, we report a novel mutation V37E
within the ®rst transmembrane domain of connexin
30 in a spontaneous case of Clouston syndrome. The
mutation was detected in genomic DNA, con®rmed
in reverse transcription polymerase chain reaction
products, and was excluded from 100 ethnically
matched control individuals by restriction enzyme
analysis. Key words: Clouston syndrome/connexin 30/gap
junction proteins/GJB6/hidrotic ectodermal dysplasia. J
Invest Dermatol 118:530±532, 2002
H
idrotic ectodermal dysplasia (HED, Clouston syn-
drome, MIM 129500) was ®rst described in 1895
(Nicolle and HallipreÂ, 1895) and later by Clouston,
in families from Quebec (Clouston, 1929, 1939).
Although most common in French Canadians, the
disorder has been identi®ed in several ethnic groups (McNaughton
et al, 1976; Rajagopalan and Tay, 1977; Ando et al, 1988; Patel et al,
1991; Radhakrishna et al, 1997; Kibar et al, 2000). The main
features of this autosomal dominant disorder are partial to complete
alopecia, palmoplantar hyperkeratosis, and nail dystrophy. Sweat
gland function in these patients is normal (Clouston, 1929; 1939).
The molecular basis of clinically similar ectodermal dysplasias
such as pachyonychia congenita are now known to be due to
mutations in the tissue-speci®c keratin genes (Irvine and McLean,
1999). Although early studies suggested Clouston syndrome could
be due to a keratin defect (Gold and Scriver, 1972; Giraud et al,
1977; Escobar et al, 1983), later genetic linkage studies excluded
both keratin gene clusters (Hay¯ick et al, 1996; Kibar et al, 1996).
Genomewide linkage analysis localized the gene to chromosome
13q11±12.1 (Kibar et al, 1996). Linkage was con®rmed by several
independent mapping studies (Radhakrishna et al, 1997; Taylor et
al, 1998; Stevens et al, 1999; Kibar et al, 2000; Lamartine et al,
2000a). These analyses demonstrated genetic homogeneity of the
disorder and a founder effect in the French Canadian population
(Kibar et al, 2000). Two candidate genes within this loci were the
gap junction proteins connexin 30 (gene name GJB6) (Kelley et al,
1999) and connexin 26 (gene name GJB2) (Lamartine et al, 2000c).
As reviewed recently, mutations in connexin 26 are associated
with disorders affecting the skin (autosomal dominant Vohwinkel
syndrome) or deafness (autosomal recessive DFNB1 or autosomal
dominant hearing loss DFNA3) (Kelsell et al, 2001). In some cases
both skin and hearing ability are affected (Kelsell et al, 2001).
Connexin 26 was excluded as a candidate for Clouston syndrome
(Kelsell et al, 1997; Lamartine et al, 2000c). Connexin 30 is also
associated with some forms of deafness (Grifa et al, 1999) and
hearing impairment has been reported in some cases of Clouston
syndrome. As connexin 30 is expressed in the epidermis (Dahl et al,
1996; Lamartine et al, 2000b) as well as in brain (Nagy et al, 1999)
and inner ear (Lautermann et al, 1999), the possibility that connexin
30 could be involved in several different phenotypes was investi-
gated. The human GJB6 gene encoding the 261 amino acid
connexin 30 polypeptide was cloned (Grifa et al, 1999) and
connexin 30 mutations were identi®ed in 12 Clouston syndrome
families of varying ethnicity (Lamartine et al, 2000b). These were
found clustered to two mutation hotspots, G11R and A88V. Here,
we report a novel connexin 30 mutation in a sporadic Scottish case
of Clouston syndrome.
MATERIALS AND METHODS
Mutation detection and con®rmation Genomic DNA was extracted
from whole blood by standard procedures. A 1104 bp fragment spanning
the full-length GJB6 gene (connexin 30) was ampli®ed with primers
Cx30P1 5¢-GGC AGG GAG TTG AAG TTG TAA-3¢ and Cx30P2
5¢ACG TTG TGTA TGA ATG GAG CA-3¢. Reactions in polymerase
chain reaction (PCR) buffer (67 mM Tris±HCl pH 8.8, 16.6 mM
(NH4)2SO4, 0.17 mg per ml bovine serum albumin, and 10 mM 2-
mercaptoethanol) containing 1.5 mM MgCl2 and 1 U Taq polymerase
(Promega) were ampli®ed as follows: 94°C 5 min 3 1; 94°C 30 s, 58°C
1 min, 72°C 2 min 3 35; and 72°C 5 min 3 1. PCR products were
puri®ed using Qiaquick PCR puri®cation kit (Qiagen, Crawley, U.K.)
and sequenced on an ABI 3100 (ABI, Foster City, CA) using primers
Cx30P1 and Cx30P2 (above).
Dermal ®broblast cells were grown from explants derived from the
patient's skin biopsy in Dulbecco's modi®ed Eagle's medium (Sigma,
Poole, U.K.) containing 10% fetal bovine serum. mRNA was extracted
using the Quickprep micro mRNA puri®cation kit (Amersham
Pharmacia Biotech UK); genomic DNA contamination was removed by
incubation with RNAse-free DNAse I (Promega) followed by phenol±
chloroform extraction and reverse transcribed using AMV reverse
transcriptase (Promega). cDNA was ampli®ed with Cx30P5 5¢-GGA
CGC TGC ACA CTT TCA TC-3¢ and Cx30P6 5¢-GCT TGG GAA
ACC TGT GAT TG-3¢ in (NH4)2SO4 PCR buffer (Bioline) containing
1.5 mM MgCl2 and 4% dimethylsulfoxide. Reactions were denatured at
94°C for 2 min, 1 U Biotaq DNA polymerase (Bioline) was added, and
reactions were ampli®ed at 94°C 5 min 3 1; 94°C 30 s, 50°C 1 min,
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72°C 2 min 3 35; and 72°C 5 min 3 1. The 783 bp fragment was
puri®ed and sequenced as above, using primers Cx30P4 5¢-GCG TCT
GTG CTC TCT TTG-3¢ and Cx30P5 (above).
Mutation V37E creates a new Xho I site, which was used to exclude
the mutation from 100 normal unrelated and ethnically matched controls.
Genomic DNA was ampli®ed with Cx30P1 and Cx30P2 (as above) and
PCR products were digested with 5 U Xho I at 37°C overnight. Digests
were analyzed on 1.5% agarose/TBE minigels.
RESULTS
Clinical ®ndings The proband, a Scottish Caucasian female, was
a sporadic case presenting with total alopecia and absent nails at
birth. By the age of 1 y, she had developed 20-nail dystrophy that
persisted in adulthood. Papular lesions were noted on the skin,
especially on the forearms, as shown in Fig 1. There was also a
diffuse, velvet-like keratoderma on the palmar and plantar surfaces
that appeared in adolescence. Tooth development, sweat gland
function, and hearing were normal. The phenotype of complete
alopecia and papular lesions suggested a diagnosis of congenital
atrichia (MIM 209500) but the presence of keratoderma was more
consistent with Clouston syndrome.
Histology A sample of buttock skin showed normal epidermis
and a normal distribution of eccrine glands (data not shown).
Remnants of hair follicles with sebaceous glands attached were
observed in the lower dermis.
Identi®cation and con®rmation of connexin 30
mutation A heterozygous missense mutation 110T ® A in the
GJB6 gene was detected by direct sequencing of PCR products
derived from genomic DNA from the affected individual (Fig 2).
This substitution leads to the predicted amino acid change V37E
within the ®rst transmembrane domain of the connexin 30
polypeptide. The mutation was also detected in cDNA
originating from dermal ®broblasts cultured from the patient's
skin biopsy (data not shown). The base change creates a new Xho I
restriction site, which was used to con®rm the presence of the
mutation in the proband by digestion of PCR products with Xho I
restriction enzyme. The mutation was excluded from 100 normal,
unrelated individuals using this screening method (Fig 2). During
the course of this investigation the hairless (HR) gene was also
screened as a candidate for mutations and the patient was found to
be heterozygous for R620Q. This amino acid change was originally
reported as a mutation in a family with congenital atrichia (Ahmad
et al, 1998) but has since been shown to be a polymorphism
(Hillmer et al, 2001).
DISCUSSION
Here we report a novel missense mutation V37E in the GJB6 gene
encoding connexin 30 in a sporadic Scottish case of Clouston
syndrome. Recently, two GJB6 mutations, G11R and A88V, in
Clouston syndrome were reported in a total of 12 families from
different ethnic populations (Lamartine et al, 2000b).
Connexins have a common structure consisting of four
transmembrane domains, two extracellular domains, and three
cytoplasmic domains. The mutation reported here, V37E, is in the
®rst of the four transmembrane domains of connexin 30. Along
with glycine 11 and alanine 88, valine 37 is conserved between
human and mouse connexin 30 and also in connexin 26, the most
Figure 1. Clinical features of the proband. (a)
Total alopecia of the scalp. Eyebrows, eyelashes,
and all other body hair was also absent (not
shown). (b) Nail dystrophy resembling
pachyonychia congenita and keratoderma
extending onto ®ngertips. (c) Papular lesions
prominently seen on the forearm.
Figure 2. Molecular genetic analysis. (a) Normal GJB6 sequence
corresponding to codons 34±38. (b) The same region of the GJB6 gene
as shown in (a), derived from the proband, showing heterozygous
missense mutation 110T ® A (arrow) predicting the amino acid change
V37E. (c) Con®rmation of mutation V37E by Xho I digestion. Lane 1,
DNA molecular weight markers; lanes 2±6, digested PCR products from
normal unrelated controls; lane 7, digested PCR product from affected
individual shows an additional band due to a new Xho I site created by
the mutation.
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closely related protein to connexin 30. A mutation in the
equivalent codon in connexin 26, V37I, has been identi®ed in
several families with recessive hearing loss with no skin abnormality
(Rabionet et al, 2000). Similarly, mutation V37M in connexin 32
causes Charcot-Marie-Tooth disease (Ikegami et al, 1998). Whereas
the latter two mutations involve substitution of one hydrophobic
amino acid for another, the V37E mutation reported here changes a
hydrophobic residue to a highly charged acidic residue. As this
occurs in a transmembrane domain, whose hydrophobic sequence
is essential for membrane spanning, this defect is predicted to be
highly detrimental to connexin 30 function.
With the recent discovery of mutations in other connexin genes
a trend is emerging whereby different mutations in the same gene
can cause different diseases. Mutations in either connexin 30 or 26
can result in deafness and/or skin pathologies and those in connexin
31 can lead to three different phenotypes. It remains to be seen how
mutations in widely expressed proteins such as connexins can result
in diverse phenotypes affecting highly speci®c epithelial compart-
ments such as the inner ear, hair, nail, and palmoplantar epidermis.
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